Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UDCA and Total Glucosides of Paeony in PBC with AIH features
NCT04618575Phase 4Unknown
- Sponsor
- West China Hospital of Sichuan University
- Start
- Mar 2021
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of total glucosides of paeony in primary biliary cholangitis (PBC), sponsored by West China Hospital of Sichuan University. Primary endpoint: Biochemical remission at 12 months. Status: unknown.
02
Drugs
total glucosides of paeony
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT04618575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04618575.